AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 11 min read$TMO

Pettiti Gianluca sold $2.5M of TMO

Pettiti Gianluca (President & COO) sold 4,133 shares of THERMO FISHER SCIENTIFIC INC. (TMO) at $614.38 ($2.54M total) across 2 trades on 2026-08-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Pettiti Gianluca
Published Sep 1, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 8:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$TMO
Bearish
medium confidence
Mentioned
$TMO
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TMOBearishLow
01

Why it matters

The filing provides the first public record of the insider's sale, offering a data point for monitoring executive sentiment.

02

Market read

While the transaction is modest, it adds to the ongoing assessment of insider activity at a large cap biotech supplier.

03

What to watch

The 10b5‑1 plan may have been set months ago, reducing the informational value of the trade.

Relevance 5/10Novelty 6/10Timing: post‑market filing on Sep 1 2026

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$TMOBearishMedium confidence
Context

President & COO Gianluca Pettiti sold 4,133 shares for $2.5M via a 10b5‑1 plan.

Expected impact

Potential short‑term pressure on TMO stock, modest downside of 1‑2%.

Evidence & confidence

The sale size is modest relative to market cap, but the insider is a senior officer and used a pre‑arranged plan, suggesting a neutral to slightly bearish signal.

Market effects

Sector

Minimal impact on the life‑science equipment sector.

Regional

No notable regional effect.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

The sale could be routine portfolio rebalancing, not a bearish signal.

Key entities

  • Company
    Thermo Fisher Scientific Inc.

    Global provider of scientific instruments and services.

  • Executive
    Gianluca Pettiti

    President & COO of Thermo Fisher Scientific.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

TMO insider trading history →

Related articles

SEP 2
$MRNAHighAI 8/10

Why Moderna's Cancer Vaccine Matters To Investors

Moderna (MRNA) and Merck (MRK) reported successful late-stage trial results for a personalized mRNA cancer vaccine targeting melanoma, reducing recurrence risk by 49%. The treatment relies on technologies from Illumina (ILMN), Danaher (DHR), and others. Moderna's stock surged 176.97% on the news, highlighting the shift toward individualized therapies in oncology.

etfdb.com3 min
SEP 1
$TMOMed

TMO Stock Could Gain Following the Launch of EMPAD G2 Detector

Thermo Fisher Scientific (TMO) launched the EMPAD G2 detector for advanced materials analysis, aiming to boost its Analytical Instruments segment. Shares dipped 0.8% post-announcement. The company has a $233.20B market cap, 4% earnings yield, and a track record of beating earnings estimates. The global 4D STEM market, where EMPAD G2 operates, is projected to grow at 6.6% CAGR through 2031, according to QYResearch.

tradingview.com3 min
AUG 26
$DALMed

CNBC’s ‘Final Trades’: Delta Air, Target, Thermo Fisher Scientific - Delta Air Lines (NYSE:DAL)

CNBC's 'Final Trades' featured picks from analysts, including Delta Air Lines (DAL) for its strong Q2 earnings, Thermo Fisher Scientific (TMO) for its raised FY2026 guidance, and Target (TGT) for its better-than-expected Q2 results. Interactive Brokers (IBKR) was also mentioned for its new Latin America funding solution. DAL +1.4%, TMO -0.1%, TGT -3.8%, IBKR +5.5%.

benzinga.com2 min